You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,206,737


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,206,737 protect, and when does it expire?

Patent 8,206,737 protects DURYSTA and is included in one NDA.

This patent has eighty-two patent family members in twenty-three countries.

Summary for Patent: 8,206,737
Title:Hypotensive lipid-containing biodegradable intraocular implants and related methods
Abstract: Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or reduce a at least one symptom of an ocular condition, such as glaucoma.
Inventor(s): Hughes; Patrick M. (Aliso Viejo, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:12/028,763
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Transforming Data into Market Domination: A Detailed Analysis of the Scope and Claims of United States Patent 8,206,737

Introduction

Understanding the scope and claims of a patent is crucial for businesses looking to protect their innovations and navigate the complex patent landscape. This article will delve into the specifics of United States Patent 8,206,737, exploring its claims, the broader patent landscape, and the implications for market domination.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of protection granted to the inventor. These claims must be clear, concise, and supported by the patent's specification[5].

Claim Structure

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: Describe the steps to achieve a particular result.
  • Apparatus Claims: Describe the physical components of the invention.

The Scope of United States Patent 8,206,737

To analyze the scope of this patent, one must review the specific claims and the context in which they are made.

Claim Analysis

  • Independent Claims: Typically, these claims will outline the broadest scope of the invention. For example, if the patent is for a new type of software, the independent claims might describe the core functionality and architecture.
  • Dependent Claims: These will narrow down the scope by adding specific limitations or features. For instance, a dependent claim might specify a particular algorithm used within the software.

Specification and Description

The patent specification provides the detailed description of the invention, including drawings and examples. This section is critical because it must support the claims and provide enough information for someone skilled in the art to replicate the invention[5].

Patent Term Adjustment (PTA) and Its Implications

Patent Term Adjustment (PTA) can significantly impact the lifespan of a patent. PTA is granted for delays caused by the USPTO during the prosecution process, extending the patent term beyond the standard 20 years from the filing date[1].

Impact on Patent Term

  • Continuations and Continuations-in-Part: Patents that are continuations or continuations-in-part of earlier patents can have different expiration dates due to PTA. This can complicate the patent landscape, especially when dealing with obviousness-type double patenting (ODP) issues[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This is particularly relevant when dealing with patent families and continuations[1].

ODP Analysis

  • Terminal Disclaimers: To overcome ODP rejections, inventors often file terminal disclaimers, which ensure that the later patent does not extend beyond the expiration date of the earlier patent. This practice is closely tied to the concept of PTA and the overall patent term[1].

The Broader Patent Landscape

Understanding the broader patent landscape is essential for market domination. Here are some key points:

Trends in Patent Activity

  • Utility Patents: The USPTO grants a significant number of utility patents each year, with a notable increase in electrical engineering and information and communication technologies (ICT) patents. In 2018, the USPTO awarded 309,000 utility patents, with businesses receiving the majority[4].
  • Technological Fields: Patents are classified under various technological fields, with electrical and mechanical engineering patents making up a substantial portion. This classification helps in understanding the competitive landscape and identifying areas of innovation[4].

Small Claims Patent Court: A New Frontier

The concept of a small claims patent court has been explored to address the high costs and complexities associated with patent litigation. This could significantly impact how small inventors and businesses protect and enforce their patents.

Feasibility and Structure

  • ACUS Study: The Administrative Conference of the United States (ACUS) conducted a study on the feasibility and potential structure of a small claims patent court. The study involved extensive public comments and input from academic experts and legal practitioners[2].

Data-Driven Insights

Using datasets like the Patent Claims Research Dataset provided by the USPTO, businesses can gain valuable insights into patent trends and scope.

Patent Claims Research Dataset

  • Detailed Information: This dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. It includes claim-level statistics and document-level statistics, providing a comprehensive view of patent scope and trends[3].

Reissue Patents and the Original Patent Requirement

Reissue patents allow for the correction of errors or the broadening of claims, but they are subject to the "original patent" requirement under 35 U.S.C. ยง 251.

Original Patent Requirement

  • Statutory Limitations: Reissue claims must be directed to the invention disclosed in the original patent. This requirement ensures that the reissue does not cover a different invention than what was originally disclosed[5].

Market Domination Strategies

To achieve market domination, businesses must strategically use their patents.

Patent Portfolio Management

  • Diversified Portfolio: Maintaining a diversified patent portfolio that includes a mix of broad and narrow claims can help in protecting various aspects of an invention.
  • Continuous Innovation: Filing continuations and continuations-in-part can help in extending the patent term and keeping the competition at bay.

Litigation and Enforcement

  • Proactive Enforcement: Proactively enforcing patents through litigation can deter competitors and protect market share.
  • Licensing and Collaboration: Licensing patents or collaborating with other companies can also be a viable strategy to expand market reach.

Key Takeaways

  • Clear Claims: Ensure that patent claims are clear, concise, and supported by the specification.
  • PTA and ODP: Understand the implications of PTA and ODP on the patent term and strategy.
  • Broader Landscape: Keep abreast of trends in patent activity and technological fields.
  • Data-Driven Insights: Use datasets to gain insights into patent trends and scope.
  • Strategic Management: Manage the patent portfolio strategically to achieve market domination.

FAQs

What is the purpose of Patent Term Adjustment (PTA)?

PTA is granted to extend the patent term due to delays caused by the USPTO during the prosecution process, ensuring that the inventor receives the full term of patent protection.

How does Obviousness-Type Double Patenting (ODP) affect patent strategy?

ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent, necessitating the use of terminal disclaimers to overcome ODP rejections.

What is the significance of the "original patent" requirement for reissue patents?

The "original patent" requirement ensures that reissue claims are directed to the invention disclosed in the original patent, preventing the broadening of claims to cover a different invention.

How can a small claims patent court impact small inventors and businesses?

A small claims patent court could provide a more accessible and cost-effective way for small inventors and businesses to protect and enforce their patents, reducing the barriers to entry in patent litigation.

What role do datasets like the Patent Claims Research Dataset play in patent strategy?

These datasets provide detailed information on patent claims and trends, enabling businesses to gain valuable insights into patent scope and make informed strategic decisions.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States.
  3. Patent Claims Research Dataset - USPTO, August 28, 2017.
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation, January 15, 2020.
  5. In Re FLOAT'N'GRILL LLC - Court of Appeals for the Federal Circuit, July 12, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,206,737

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie DURYSTA bimatoprost IMPLANT;OPHTHALMIC 211911-001 Mar 4, 2020 RX Yes Yes 8,206,737 ⤷  Subscribe REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN ANGLE GLAUCOMA(OAG) OR OCULAR HYPERTENSION (OHT) WITH A BIODEGRADABLE BIMATOPROST IMPLANT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,206,737

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E397934 ⤷  Subscribe
Australia 2005244203 ⤷  Subscribe
Australia 2007223057 ⤷  Subscribe
Australia 2011239642 ⤷  Subscribe
Brazil 112012026535 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.